Canature Health Technology300272.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Canature Health Technology (300272.SZ) trades at a P/E of 119.00x, P/B of 2.79x, P/S of 1.91x, and a dividend yield of 3.12%.
Longitudinal percentile comparison: P/E sits at the 98th percentile over the trailing 10Y window (vs. 92nd percentile over 3Y); P/B sits at the 35th percentile over the trailing 10Y window (vs. 33rd percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 19th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 87th percentile within its industry and the 84th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.12%, ranking at the 94th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 62.3 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Canature Health Technology operates in the Home Appliance sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300272 · SZSE: 300272 · 300272
Want the full picture on whether Canature Health Technology (300272.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 119.00 | ||||||
| P/B (MRQ) | 2.79 | ||||||
| P/S (TTM) | 1.91 | ||||||
| Dividend Yield | 3.12% | ||||||
| Buyback + Div Yield | 3.12% |